Evidence map›Paper›PMID 28608001›Full record

ArticleCellular and molecular neurobiology2018

Anti-Zn

Lidan Luo, Seung-Woo Kim, Hye-Kyung Lee, Il-Doo Kim, Hahnbie Lee, Ja-Kyeong Lee

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Neuropharmacological effects ofFrontiers in neurology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Oxidative medicine and cellular longevity · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lidan LuoDepartment of Anatomy, Inha University School of Medicine, Nam-Gu Inharo 100, Inchon, 22212, Republic of Korea.
Seung-Woo KimDepartment of Biomedical Sciences, Inha University School of Medicine, Inchon, Republic of Korea.
Hye-Kyung LeeDepartment of Anatomy, Inha University School of Medicine, Nam-Gu Inharo 100, Inchon, 22212, Republic of Korea.
Il-Doo KimDepartment of Anatomy, Inha University School of Medicine, Nam-Gu Inharo 100, Inchon, 22212, Republic of Korea.
Hahnbie LeeDepartment of Anatomy, Inha University School of Medicine, Nam-Gu Inharo 100, Inchon, 22212, Republic of Korea.
Ja-Kyeong LeeDepartment of Anatomy, Inha University School of Medicine, Nam-Gu Inharo 100, Inchon, 22212, Republic of Korea. jklee@inha.ac.kr.
Inha University · KR

Funding

Korea Health Industry Development Institute (KR) HI13C1417National Research Foundation (NRF) of Korea 2015R1A2A2A01003395
6 · The paper itself

Abstract

4-Hydroxybenzyl alcohol (4-HBA) is an important phenolic constituent of Gastrodia elata (GE) Blume, which is used as a traditional herbal medicine in East Asia. Many activities have been reported to underlie the beneficial effects of 4-HBA in brain, such as, anti-oxidative, anti-inflammatory, anti-excitotoxic, and anti-apoptotic effects in neurons and microglia. Here, the authors demonstrate the robust neuroprotective effects of 4-HBA in rat middle cerebral artery occlusion (MCAO) model of stroke, and showed anti-Zn

Indexed as

AnimalsAnti-Inflammatory AgentsApoptosisAstrocytesBenzyl AlcoholsBrainBrain IschemiaCell DeathInfarction, Middle Cerebral ArteryMaleNeuronsNeuroprotective AgentsRats, Sprague-Dawley4-hydroxybenzyl alcoholAnti-Inflammatory AgentsBenzyl AlcoholsNeuroprotective Agents4-Hydroxybenzyl alcoholAnti-Zn2+-toxicityAstrocyteMCAONeuroprotection

Identifiers

PMID28608001
PMCPMC11481900
OpenAlexW2625532634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.